000 | 01026 a2200277 4500 | ||
---|---|---|---|
005 | 20250515104608.0 | ||
264 | 0 | _c20080724 | |
008 | 200807s 0 0 eng d | ||
022 | _a1745-8331 | ||
024 | 7 |
_a10.1038/ncpneph0710 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpiegel, David M | |
245 | 0 | 0 |
_aShould we be using calcium-containing phosphate binders in patients on dialysis? _h[electronic resource] |
260 |
_bNature clinical practice. Nephrology _cMar 2008 |
||
300 |
_a118-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aCalcium Compounds _xadverse effects |
650 | 0 | 4 |
_aChelating Agents _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypercalcemia _xchemically induced |
650 | 0 | 4 |
_aHyperphosphatemia _xprevention & control |
650 | 0 | 4 | _aRenal Dialysis |
700 | 1 | _aBlock, Geoffrey A | |
773 | 0 |
_tNature clinical practice. Nephrology _gvol. 4 _gno. 3 _gp. 118-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/ncpneph0710 _zAvailable from publisher's website |
999 |
_c17720306 _d17720306 |